<DOC>
	<DOCNO>NCT02229838</DOCNO>
	<brief_summary>Safety , pharmacodynamics pharmacokinetics 0.25 , 0.75 , 2.0 , 6.0 , 10 mg BIBB 1464 p.o daily rise dose group-comparison ( placebo control , double blind , randomize per dose level ) . Relative Bioavailability 0.75 mg 2 mg 6 mg ( tablet vs. solution , intraindividual comparison ) , preliminary assessment food effect ( interindividual comparison ) Two-stage Trial Design With Randomised Double Blind Placebo Controlled Rising Dose Phase Subsequent Randomised , Open Parallel Group Phase ) . MS ( Tablet ) Healthy Male Subjects , Combined With Preliminary Evaluation Relative Bioavailability Effect Food Dose 0.75 mg 2 mg 6 mg ( Two-stage Trial Design With Randomised Double Blind Placebo Controlled Rising Dose Phase Subsequent Randomised , Open Parallel Group Phase ) .</brief_summary>
	<brief_title>Safety/Tolerability , Pharmacokinetics , Pharmacodynamics BIBB 1464 MS Healthy Male Subjects , Combined With Preliminary Evaluation Relative Bioavailability Effect Food</brief_title>
	<detailed_description />
	<criteria>Healthy subject determine result screen Signed write informed consent accordance good clinical practice ( GCP ) local legislation Age &gt; 18 &lt; 55 year Broca &gt; 20 % &lt; + 20 % Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal ( include thyroid ) disorder Surgery gastrointestinal tract ( except appendectomy ) Disease central nervous system ( epilepsy ) psychiatric disorder Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( &lt; = 1 month prior administration trial ) Use drug might influence result trial ( &lt; = 10 day prior administration trial ) Participation another trial investigational drug ( &lt; = 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke period study Known alcohol ( &gt; 60 g/day ) drug abuse Blood donation ( &lt; =1 month prior administration ) Excessive physical activity ( &lt; 5 day prior administration ) Any laboratory value outside normal range clinical relevance History hemorrhagic diatheses History gastrointestinal ulcer , perforation bleed History bronchial asthma</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>